Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00098046 · ClinicalTrials.gov registry record · Phase 3
Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 76
- Enrollment target
NCT00098046 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 76 participants.
The verdict
NCT00098046, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 76 participants
- Enrollment target
Study Summary
Varicella zoster virus causes chickenpox in children and shingles in adults. Chickenpox is usually a self-limiting illness characterized by fever and a rash. Serious complications can include secondary bacterial infections, pneumonia, and encephalitis. Anti-viral treatment is not a standard of care in immunocompetent children, but is recommended whenever a risk of complication exists. This study will evaluate the safety and blood levels of a new formulation of famciclovir in children 1-12 years of age.
Interventions
- DRUG famciclovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2005-07 |
| Est. Completion | 2007-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00098046
The ClinicalTrials.gov registry entry for NCT00098046 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which famciclovir is the first listed.
NCT00098046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00098046 about?
NCT00098046 is a clinical study titled "Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection". Varicella zoster virus causes chickenpox in children and shingles in adults. Chickenpox is usually a self-limiting illness characterized by fever and a rash. Serious complications can include secondary bacterial infections, pneumonia, and encephalitis. Anti-viral treatment is not a standard of care ...
What is the current status of trial NCT00098046?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 76 participants. The study started on 2005-07. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00098046?
The interventions under investigation include: famciclovir (DRUG).
Who is sponsoring clinical trial NCT00098046?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.